Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and Phenotypes
Open Access
- 1 October 2017
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 74 (10) , 1228-1236
Abstract
Early infantile epileptic encephalopathies (EEs) form a group of disorders that are characterized by epileptic seizures starting during the first year of life. Patients have developmental delay (DD) or even regression to which the epileptic discharges are presumed to contribute. The seizures are often unresponsive to treatment. Many of those epilepsies have a genetic disposition.1Keywords
This publication has 27 references indexed in Scilit:
- A novel epileptic encephalopathy mutation in KCNB1 disrupts Kv2.1 ion selectivity, expression, and localizationJournal of General Physiology, 2015
- Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disordersScience Translational Medicine, 2014
- SMART: recent updates, new developments and status in 2015Nucleic Acids Research, 2014
- A framework for the interpretation of de novo mutation in human diseaseNature Genetics, 2014
- Clinical whole exome sequencing in child neurology practiceAnnals of Neurology, 2014
- Deletion of the Kv2.1 delayed rectifier potassium channel leads to neuronal and behavioral hyperexcitabilityGenes, Brain and Behavior, 2014
- De novo mutations in epileptic encephalopathiesNature, 2013
- KCNQ2 encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathyAnnals of Neurology, 2011
- Nonsense-mediated mRNA decay: terminating erroneous gene expressionCurrent Opinion in Cell Biology, 2004
- Heteromultimeric channels formed by rat brain potassium-channel proteinsNature, 1990